C78801

ペラルゴン酸コレステリル

97%

• 別名: 3-ノナン酸3β-ヒドロキシ-5-コレステン, 3-ノナン酸5-コレステン-3β-オール, ノナン酸コレステリル
• 実験式（ヒル表記法）: C₃₆H₆₂O₂
• CAS番号: 1182-66-7
• 分子量: 526.88
• Beilstein: 3179820
• EC Number: 214-658-3
• MDL番号: MFCD00003643
• UNSPSCコード: 12352103
• PubChem Substance ID: 24892993
• NACRES: NA.23

特性

• アッセイ: 97%
• 形状: liquid crystal
• 光学活性: [α]25/D −30°, c = 2 in chloroform
• mp: 74-77 °C (lit.)
• 転移温度: crystalline phase to smectic phase 77.5 °C; smectic phase to cholesteric phase 79 °C; cholesteric phase to isotropic phase 90 °C
• SMILES記法: CCCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C
• InChI: 1S/C36H62O2/c1-7-8-9-10-11-12-16-34(37)38-29-21-23-35(5)28(25-29)17-18-30-32-20-19-31(27(4)15-13-14-26(2)3)36(32,6)24-22-33(30)35/h17,26-27,29-33H,7-16,18-25H2,1-6H3/t27-,29+,30+,31-,32+,33+,35+,36-/m1/s1
• InChI Key: WCLNGBQPTVENHV-MKQVXYPISA-N

詳細

アプリケーション

• Liquid Crystal Modified Polylactic Acid Improves Cytocompatibility and M2 Polarization of Macrophages to Promote Osteogenesis: A series of composite films were prepared using cholesteryl oleyl carbonate, cholesteryl pelargonate, and polylactic acid for biomedical applications (Z Zheng et al., 2022).


• Site-selective and stereoselective functionalization of non-activated tertiary C–H bonds: Describes the Rh-catalyzed reaction with cholesteryl pelargonate for selective functionalization (K Liao et al., 2017).


• Cholesteryl ester liquid crystal nanofibers for tissue engineering applications: Development of nanofibers using cholesteryl pelargonate for enhanced tissue engineering applications (A Nasajpour et al., 2020).

安全性情報

• 危険有害性情報: H413
• 注意書き: P273
• 危険有害性の分類: Aquatic Chronic 4
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable
• 個人用保護具 (PPE): Eyeshields, Gloves, type N95 (US)